J. Han

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

Lawrence Blonde, E. Klein, J. Han et al. · Diabetes Obesity and Metabolism · 2006 · 418 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects

C. Ellero, J. Han, Sunil Bhavsar et al. · Diabetic Medicine · 2010 · 34 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Is insulin the most effective injectable antihyperglycaemic therapy?

John B. Buse, Anne L. Peters, David Russell‐Jones et al. · Diabetes Obesity and Metabolism · 2014 · 32 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an <scp>HbA1c</scp> &lt; 7%, without weight gain or hypoglycaemia, over 52 weeks

Richard M. Bergenstal, Y. Li, T. K. Booker Porter et al. · Diabetes Obesity and Metabolism · 2012 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis

J. Han, Lu Guo, Xianhui Chen et al. · Medicine · 2024 · 22 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +9